Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical trials of P-glycoprotein reversal in solid tumours.

× No keyword cloud information.

49 in total

1. Molecular Events as Targets of Anticancer Drug Therapy.

Authors: Adorján Aszalós; Sándor Eckhardt
Journal: Pathol Oncol Res Date: 1997 Impact factor: 3.201

Review 2. The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Authors: H A Bardelmeijer; O van Tellingen; J H Schellens; J H Beijnen
Journal: Invest New Drugs Date: 2000-08 Impact factor: 3.850

Review 3. Breast cancer therapies in development. A review of their pharmacology and clinical potential.

Authors: D de Valeriola; A Awada; J A Roy; A Di Leo; L Biganzoli; M Piccart
Journal: Drugs Date: 1997-09 Impact factor: 9.546

Review 4. Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors: Gloria Lee; Reina Bendayan
Journal: Pharm Res Date: 2004-08 Impact factor: 4.200

5. Activity of doxorubicin covalently bound to a novel human serum albumin microcapsule.

Authors: M Eatock; N Church; R Harris; W Angerson; C McArdle; R French; C Twelves
Journal: Invest New Drugs Date: 1999 Impact factor: 3.850

6. Advances of cancer therapy by nanotechnology.

Authors: Xu Wang; Yiqing Wang; Zhuo Georgia Chen; Dong M Shin
Journal: Cancer Res Treat Date: 2009-03-31 Impact factor: 4.679

7. A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.

Authors: Xu Wang; Jun Li; Yuxiang Wang; Lydia Koenig; Ada Gjyrezi; Paraskevi Giannakakou; Edwin H Shin; Mourad Tighiouart; Zhuo Georgia Chen; Shuming Nie; Dong M Shin
Journal: ACS Nano Date: 2011-07-11 Impact factor: 15.881

8. Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.

Authors: Todd Hulgan; John P Donahue; Laura Smeaton; Minya Pu; Hongying Wang; Michael M Lederman; Kimberly Smith; Hernan Valdez; Christopher Pilcher; David W Haas
Journal: Eur J Clin Pharmacol Date: 2009-11 Impact factor: 2.953

9. NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.

Authors: Zhenfeng Duan; Edwin Choy; Francis J Hornicek
Journal: PLoS One Date: 2009-10-12 Impact factor: 3.240

10. The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors.

Authors: Krupa J Patel; Ian F Tannock
Journal: BMC Cancer Date: 2009-10-06 Impact factor: 4.430